Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Viridian Therapeutics, Inc.\DE (VRDN) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Viridian Therapeutics, Inc.\DE (VRDN) over the last 9 years, with Q3 2025 value amounting to 0.04.

  • Viridian Therapeutics, Inc.\DE's Debt Ratio rose 3613.79% to 0.04 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04, marking a year-over-year increase of 3613.79%. This contributed to the annual value of 0.03 for FY2024, which is 3270.84% down from last year.
  • Latest data reveals that Viridian Therapeutics, Inc.\DE reported Debt Ratio of 0.04 as of Q3 2025, which was up 3613.79% from 0.04 recorded in Q2 2025.
  • In the past 5 years, Viridian Therapeutics, Inc.\DE's Debt Ratio registered a high of 0.04 during Q4 2023, and its lowest value of 0.03 during Q3 2024.
  • In the last 3 years, Viridian Therapeutics, Inc.\DE's Debt Ratio had a median value of 0.03 in 2024 and averaged 0.03.
  • Per our database at Business Quant, Viridian Therapeutics, Inc.\DE's Debt Ratio crashed by 3270.84% in 2024 and then surged by 3613.79% in 2025.
  • Quarter analysis of 3 years shows Viridian Therapeutics, Inc.\DE's Debt Ratio stood at 0.04 in 2023, then tumbled by 32.71% to 0.03 in 2024, then skyrocketed by 30.56% to 0.04 in 2025.
  • Its last three reported values are 0.04 in Q3 2025, 0.04 for Q2 2025, and 0.03 during Q1 2025.